Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT06652321Not ApplicableRecruiting

Endothelial Side Up Inverted Femtosecond Laser Assisted DSAEK

Role: lead

NCT05847049Completed

Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta Chment in Central Serous Chorioretinopathy

Role: lead

NCT05847088Completed

Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema:

Role: lead

NCT05817630Completed

Duration of Silicone Oil Tamponade on Foveal and Parafoveal Thickness in Rhegmatogenous Retinal Detachment

Role: lead

NCT05716932Completed

Focal Laser Single Intravitreal Ranibizumab Retinal Artery Macroaneurysm.

Role: lead

NCT05716971Completed

Redetachment Under Densiron for RD Multiple Breaks

Role: lead

NCT03638726Phase 4Unknown

Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification

Role: lead

NCT03218371Completed

Scleral Self-indentation Chandelier-assisted Peripheral Vitrectomy Under Air Rhegmatogenous Retinal Detachment.

Role: lead

All 8 trials loaded